Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Pozycja w akcjach #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Cena akcji
$0.00695
Ostatnia synchronizacja: 2024-10-29
Kapitalizacja rynkowa
$536.40
Zmiana (1 dzień)
-0.71%
Zmiana (1 rok)
0.00%
Kraj
US
Handel BIOLASE, Inc. (BIOL)

Kategoria

Przychody dla BIOLASE, Inc. (BIOL)
Przychody w Sep 2024 TTM: $46.03M
Według najnowszych raportów finansowych BIOLASE, Inc., obecny przychód firmy (TTM) wynosi $46.03M. W roku 2022 firma osiągnęła przychód w wysokości $48.46M wzrost w porównaniu do przychodu z roku 2021, który wynosił $39.19M. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy BIOLASE, Inc. od 2000 do 2026
Przychody na koniec każdego roku
Rok Przychody Zmień
2026 (TTM) $46.03M -6.38%
2023 $49.16M 1.45%
2022 $48.46M 23.67%
2021 $39.19M 72.03%
2020 $22.78M -39.73%
2019 $37.80M -18.10%
2018 $46.16M -1.64%
2017 $46.93M -9.43%
2016 $51.81M 6.88%
2015 $48.48M 1.72%
2014 $47.66M -15.55%
2013 $56.43M -1.61%
2012 $57.36M 17.39%
2011 $48.86M 86.30%
2010 $26.23M -39.50%
2009 $43.35M -32.93%
2008 $64.63M -3.38%
2007 $66.89M -4.03%
2006 $69.70M 12.46%
2005 $61.98M 2.19%
2004 $60.65M 23.57%
2003 $49.08M 68.09%
2002 $29.20M 63.24%
2001 $17.89M 85.22%
2000 $9.66M 0.00%
Przychody podobnych firm lub konkurentów
Firma Przychody Różnica w przychodach Kraj
$46.59B 101,114.53%
US
$25.84B 56,035.66%
US
$35.48B 76,995.55%
IE
$21.00B 45,517.69%
US
$6.51B 14,049.18%
US